Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

10.62
Delayed Data
As of 12:52pm ET
 -0.18 / -1.67%
Today’s Change
8.27
Today|||52-Week Range
28.48
-33.71%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close10.80
Today’s open10.82
Day’s range10.48 - 10.82
Volume33,295
Average volume (3 months)390,571
Market cap$618.0M
Dividend yield--
Data as of 12:52pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.09-0.56%
CLVSClovis Oncology Inc+0.36+2.25%
KERXKeryx Biopharmaceuti...+0.14+2.46%
CORTCorcept Therapeutics...-0.01-0.18%
Data as of 1:10pm ET, 05/26/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs